ESR1 and cancer: In the case of ERα-negative BRCA cells, in vivo and in vitro studies have demonstrated that CPT provided its anti-cancer effect through GPER-mediated pathways, apoptosis via reactive oxygen species, and to a lesser extent through regulation of gene expression.